Market Share of Predictive and Presymptomatic Testing Industry
The predictive and presymptomatic testing market is moderately competitive and is majorly comprised of local players in different countries. Some of the global players such as 23andMe, Abbott Laboratories, and Myriad Genetics hold a major share of the market. With the growing focus on genetic testing, it is expected that a few small to mid-sized companies will penetrate the market in the near future.
Predictive and Presymptomatic Testing Market Leaders
23andMe
Abbott Laboratories
Quest Diagnostics Inc.
Myriad Genetics
Positive Bioscience
*Disclaimer: Major Players sorted in no particular order
